EUVIMEDEUVIMED entdecken
Crossref

Patient selection in sham-controlled trials of antireflux mucosal ablation: who benefits and why?

Varan Perananthan iD, Francesco Vito Mandarino iD

Endoscopy · 01.09.2026 · 58 (09) · 1067

DOI: 10.1055/a-2890-0493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.09.2026. Verfasst von Varan Perananthan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic, Rochester, Division of Gastroenterology and Hepatology, Minnesota, United States, Rochester.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Mayo Clinic, Rochester, Division of Gastroenterology and Hepatology, Minnesota, United States, Rochester.
  • IRCCS San Raffaele Hospital, Gastroenterology and Gastrointestinal Endoscopy Unit, Italy, Milan.

ORCID-Profile: Varan Perananthan, Francesco Vito Mandarino

Zitieren

APA

Perananthan, V., & Mandarino, F. V. (2026). Patient selection in sham-controlled trials of antireflux mucosal ablation: who benefits and why?. Endoscopy, 58(09), 1067. https://doi.org/10.1055/a-2890-0493

Vancouver

Perananthan V, Mandarino FV. Patient selection in sham-controlled trials of antireflux mucosal ablation: who benefits and why?. Endoscopy. 2026;58(09):1067. doi:10.1055/a-2890-0493

BibTeX
@article{Perananthan2026,
  author = {Perananthan, Varan and Mandarino, Francesco Vito},
  title = {Patient selection in sham-controlled trials of antireflux mucosal ablation: who benefits and why?},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {09},
  pages = {1067},
  doi = {10.1055/a-2890-0493}
}
Kostenlos starten →